Impairment in cytotoxicity and expression of NK cell-activating receptors on human NK cells following exposure to asbestos fibers

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 3, 2009, Pages 579-590

  Nishimura, Yasumitsu ^a   Miura, Y ^a,b   Maeda, M ^a   Kumagai, N ^a,c   Murakami, S ^a   Hayashi, H ^a   Fukuoka, K ^d   Nakano, T ^d   Otsuki, T ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Asbestos; Cytotoxicity; Natural killer cell; NK cell activating receptor

Indexed keywords

CELL PROTEIN; CHRYSOTILE; GRANZYME A; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN 2B4; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MESOTHELIOMA; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD; ASBESTOS, SERPENTINE; CASE-CONTROL STUDIES; CELL DEGRANULATION; CELL SURVIVAL; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GRANZYMES; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MESOTHELIOMA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PERFORIN; RECEPTORS, IMMUNOLOGIC; TIME FACTORS;

EID: 70350542506     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200304     Document Type: Article

References (30)

1. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998; 157:1666-1680
2. Roggli VL, Oury TD, Sporn TA. Asbestos-Associated Diseases. Springer-Verlag. New York, 2004.
3. Dusinska M, Collins A, Kazimirova A, et al. Genotoxic effects of asbestos in humans. Mutat Res 2004; 553:91-102.
4. Topinka J, Loli P, Georgiadis P, et al. Mutagenesis by asbestos in the lung of lambda-lacI transgenic rats. Mutat Res 2004; 553:67-78. (Pubitemid 38996797)
5. McDonald AD, McDonald JC. Mesothelioma after crocidolite exposure during gas mask manufacture. Environ Res 1978; 17:340-346
6. Selikoff IJ, Hammond EC, Seidman H. Mortality experience of insulation workers in the United States and Canada, 1943-1976. Ann NY Acad Sci 1979; 330:91-116.
7. Selikoff IJ, Hammond EC, Seidman H. Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 1980; 46:2736-2740 (Pubitemid 11210245)
8. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004; 23:255-259 (Pubitemid 38294490)
9. Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003; 3:304-316
10. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19:197-223. (Pubitemid 32368034)
11. Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R, Moretta L, Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol 1999; 29: 1656-1666 (Pubitemid 29224471)
12. Endt J, Eissmann P, Hoffmann SC, Meinke S, Giese T, Watzl C. Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells. Eur J Immunol 2007; 37:193-198 (Pubitemid 46128799)
13. Garni-Wagner BA, Purohit A, Mathew PA, Bennett M, Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 1993; 151:60-70. (Pubitemid 23206971)
14. Valiante NM, Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med 1993; 178:1397-406. (Pubitemid 23277371)
15. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002; 2:735-747 (Pubitemid 37328714)
16. Johann S, Blumel G, Lipp M, Forster R. A versatile flow cytometry-based assay for the determination of short- and long-term natural killer cell activity. J Immunol Methods 1995; 185:209-216
17. Bryceson YT, March ME, Barber DF, Ljunggren HG, Long EO. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 2005; 202:1001-1012
18. Fauriat C, Just-Landi S, Mallet F, Arnoulet C, Sainty D, Olive D, Costello RT. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood 2007; 109:323-330 (Pubitemid 46053073)
19. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294:15-22. (Pubitemid 39626587)
20. Bryceson YT, Rudd E, Zheng C, et al. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 2007; 110:1906-1915
21. Winer BJ, Brown DR, Michels KM. Multifactor experiments having repeated measures on the same elements. In Statistical principles in experimental design. M.E. Chiappetta, J. Vaicunas, J.M. Morriss, ed. McGraw-Hill, Inc. New York, 1991; p. 497.
22. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006; 7:507-516
23. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007; 26:503-517 (Pubitemid 46602996)
24. Barber MA, Zhang T, Gagne BA, Sentman CL. NK cells negatively regulate antigen presentation and tumor-specific CTLs in a syngeneic lymphoma model. J Immunol 2007; 178:6140-6147 (Pubitemid 46717395)
25. Guan H, Moretto M, Bzik DJ, Gigley J, Khan IA. NK cells enhance dendritic cell response against parasite antigens via NKG2D pathway. J Immunol 2007; 179:590-596 (Pubitemid 46986576)
26. Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 2006; 176:1582-1587
27. Chen X, Trivedi PP, Ge B, Krzewski K, Strominger JL. Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity. Proc Natl Acad Sci USA 2007; 104:6329-6334 (Pubitemid 47186094)
28. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T. The trafficking of natural killer cells. Immunol Rev 2007; 220:169-182
29. Dodson RF, Williams MG, Jr., Corn CJ, Brollo A, Bianchi C. A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques. Ann NY Acad Sci 1991; 643:53-60.
30. Miserocchi G, Sancini G, Mantegazza F, Chiappino G. Translocation pathways for inhaled asbestos fibers. Environ Health 2008; 7:4. (Pubitemid 351357313)